Table 1 Correlation between BANCR expression and different clinicopathological features in patients with hepatocellular carcinoma
Clinicopathological features | No. of cases | BANCR expression | P | |
|---|---|---|---|---|
Low (n, %) | High (n, %) | |||
Age | ||||
<60 | 53 | 29 (54.7 %) | 24 (45.3 %) | 0.845 |
≥60 | 56 | 26 (46.4 %) | 30 (53.6 %) | |
Gender | ||||
Male | 80 | 39 (48.8 %) | 41 (51.2 %) | 0.666 |
Female | 29 | 16 (55.2 %) | 13 (44.8 %) | |
Tumor grade | ||||
G1 | 34 | 24 (70.6 %) | 10 (29.4 %) | 0.007 |
G2 + G3 | 75 | 31 (41.3 %) | 44 (58.7 %) | |
AFP (ng/L) | ||||
≥400 | 61 | 27 (44.4 %) | 34 (55.6 %) | 0.178 |
<400 | 48 | 28 (58.3 %) | 20 (41.7 %) | |
With cirrhosis | ||||
Yes | 74 | 36 (48.6 %) | 38 (51.4 %) | 0.683 |
No | 35 | 19 (54.3 %) | 16 (45.7 %) | |
Tumor diameter (cm) | ||||
<5 | 66 | 41 (62.1 %) | 25 (37.9 %) | 0.003 |
≥5 | 43 | 14 (32.6 %) | 29 (67.4 %) | |
Tumor nodes | ||||
Multi | 37 | 15 (40.5 %) | 22 (59.5 %) | 0.16 |
Single | 72 | 40 (55.6 %) | 32 (44.4 %) | |
Venous infiltration | ||||
Presence | 39 | 11 (28.2 %) | 28 (71.8 %) | 0.001 |
Absence | 70 | 44 (62.9 %) | 26 (37.1 %) | |
TNM stage | ||||
I + II | 51 | 34 (66.7 %) | 17 (33.3 %) | 0.002 |
III | 58 | 21 (36.2 %) | 37 (66.8 %) | |